Form D · Other

Aleafia Health Inc.

Concord, A6 · CIK 0001754664

Offering snapshot reported Jul 2, 2019 · SEC filing

Reported sold: $34.3K
Investors reported: 1
Minimum accepted: $0
First sale: Jun 27, 2019

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jul 2, 2019	Initial	$34,321	No comparison	1	SEC filing
Dec 6, 2018	Initial	$16,660,600	No comparison	1	SEC filing

Offering details

Securities: Equity, Debt, Security to be acquired, Other
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $2.06K
Finders' fees: $0
Form D file number: 021-343327

Each Unit consist of 1 CAD$1000 unsecured convertible debenture with interest at 8.5% per annum & 680 common share purchase warrants exercisable for CAD$1.55 per share for 3 years from the closing date.

6% of gross proceeds

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Mackie Research USA Inc	39670

Source: Form D, filed Jul 2, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Geoffrey Benic	Executive
Julian Fantino	Director
Benjamin Ferdinand	Executive
Gary Goodyear	Director
Loreto Grimaldi	Director
Daniel Milliard	Director
Lea Ray	Director
Mark Sandler	Director
Raf Souccar	Director
William Stewart	Director
Michael Verbora	Director

Issuer details

Industry: Other (See others in industry)

Address:

8810 Jane Street, 2 Nd Floor
Concord, A6, L4K2M9